Size-selective fishing drives species composition in the Celtic Sea

Fishing alters community size structure by selectively removing larger individual fish and by changing the relative abundance of different-sized species. To assess the relative importance of individual-and species-level effects, two indices of fish community structure were compared, the relative abundance of large fish individuals (large fish indicator, LFI) and the relative abundance of large fish species (large species indicator, LSI). The two indices were strongly correlated for empirical data from the Celtic Sea and for data from simulated model communities, suggesting that much of the variability in the LFI is caused by shifts in the relative abundance of species (LSI). This correlation is explained by the observation that most of the biomass of a given species is spread over few length classes, a range spanning the factor 2 of individual length, such that most species contributed predominantly to either the small or the large component of the LFI. The results suggest that the effects of size-selective fishing in the Celtic Sea are mediated mainly through changes in community composition.

Recent data suggest no further recovery in North Sea Large Fish Indicator

We detail the calculations of North Sea Large Fish Indicator values for 2009-2011, demonstrating an apparent stall in recovery. Therefore, recovery to the Marine Strategy Framework Directive's good environmental status of 0.3 by the 2020 deadline now looks less certain and may take longer than was expected using data from 2006 to 2008.

Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes

Overexpression of MN1, ERG, BAALC, and EVI1 (MEBE) genes in cytogenetically normal acute myeloid leukemia (AML) patients is associated with poor prognosis, but their prognostic effect in patients with myelodysplastic syndromes (MDS) has not been studied systematically. Expression data of the four genes from 140 MDS patients were combined in an additive score, which was validated in an independent patient cohort of 110 MDS patients. A high MEBE score, defined as high expression of at least two of the four genes, predicted a significantly shorter overall survival (OS) (HR 2.29, 95 % CI 1.3-4.09, P?=?.005) and time to AML progression (HR 4.83, 95 % CI 2.01-11.57, P?